A breast cancer drug that was rejected for routine NHS use in England earlier this year has now been recommended by health officials after a discount was agreed with the manufacturer. The Guardian
Thursday 12 August 2021
Breast cancer drug approved for NHS after maker agrees discount
Breast cancer drug approved for NHS after maker agrees discount Reversal of earlier rejection by Nice of abemaciclib – known as Verzenios – is welcomed by campaigners
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment